Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

被引:24
|
作者
Alaaeldin, Rania [1 ]
Ali, Fares E. M. [2 ]
Bekhit, Amany Abdlrehim [3 ]
Zhao, Qing-Li [4 ]
Fathy, Moustafa [3 ,5 ]
机构
[1] Deraya Univ, Fac Pharm, Dept Biochem, Al Minya 61111, Egypt
[2] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Assiut Branch, Assiut 71524, Egypt
[3] Minia Univ, Fac Pharm, Dept Biochem, Al Minya 61519, Egypt
[4] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 9300194, Japan
[5] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
azilsartan; breast cancer; NF-kB; EMT; IL-6; JAK2; STAT3; SLUG; TWIST; SNAIL; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; APOPTOSIS; RECEPTOR; EMT; COMBINATIONS; INFLAMMATION; MODULATION; MIGRATION; SLUG;
D O I
10.3390/molecules27227825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the first time, the anti-proliferative activity of azilsartan, an angiotensin II receptor blocker, against breast cancer cell lines MCF-7 and MDA-MB-231 at the molecular level. Cell viability, cell cycle, apoptosis, colony formation, and cell migration assays were performed. RT-PCR and western blotting analysis were used to explain the molecular mechanism. Azilsartan significantly decreased the cancer cells survival, induced apoptosis and cell cycle arrest, and inhibited colony formation and cell migration abilities. Furthermore, azilsartan reduced the mRNA levels of NF-kB, TWIST, SNAIL, SLUG and bcl2, and increased the mRNA level of bax. Additionally, azilsartan inhibited the expression of IL-6, JAK2, STAT3, MMP9 and bcl2 proteins, and increased the expression of bax, c-PARP and cleaved caspase 3 protein. Interestingly, it reduced the in vivo metastatic capacity of MDA-MBA-231 breast cancer cells. In conclusion, the present study revealed, for the first time, the anti-proliferative, apoptotic, anti-migration and EMT inhibition activities of azilsartan against breast cancer cells through modulating NF-kB/IL-6/JAK2/STAT3/MMP9, TWIST/SNAIL/SLUG and apoptosis signaling pathways.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
    Wu, Xiongyan
    Tao, Pan
    Zhou, Quan
    Li, Jie
    Yu, Zhenjia
    Wang, Xiaofeng
    Li, Jiaanfang
    Li, Chen
    Yan, Min
    Zhu, Zhenggang
    Liu, Bingya
    Su, Liping
    [J]. ONCOTARGET, 2017, 8 (13) : 20741 - 20750
  • [2] IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway
    Xiao, Jing
    Gong, Yanan
    Chen, Ying
    Yu, Dahai
    Wang, Xiaoyang
    Zhang, Xiaoxue
    Dou, Yanna
    Liu, Dong
    Cheng, Genyang
    Lu, Shan
    Yuan, Wenming
    Li, Yansheng
    Zhao, Zhanzheng
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 313 (02) : F310 - F318
  • [3] Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway
    Hsu, Han-Shui
    Lin, Jiun-Han
    Hsu, Tien-Wei
    Su, Kelly
    Wang, Cheng-Wien
    Yang, Kuang-Yao
    Chiou, Shih-Hwa
    Hung, Shih-Chieh
    [J]. LUNG CANCER, 2012, 75 (02) : 167 - 177
  • [4] PDSS2 Promotes Epithelial-Mesenchymal Transition and Angiogenesis in Breast Cancer Cells by Activating the NF-KB Pathway
    Shi, Zhijie
    Wu, Deqi
    Hu, Yangying
    Zheng, Shusen
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2551 - 2560
  • [5] Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells
    Gao, Yebo
    Li, Weidong
    Liu, Rui
    Guo, Qiujun
    Li, Jie
    Bao, Yanju
    Zheng, Honggang
    Jiang, Shulong
    Hua, Baojin
    [J]. ONCOLOGY REPORTS, 2017, 38 (02) : 1224 - 1232
  • [6] ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma
    Zhao, Xin
    Ma, Weiguo
    Li, Xinyu
    Li, Haijun
    Li, Jin
    Li, Hongle
    He, Fucheng
    [J]. JOURNAL OF CANCER, 2021, 12 (05): : 1295 - 1306
  • [7] The role of IL-6/JAK2/STAT3 signaling pathway in cancers
    Huang, Bei
    Lang, Xiaoling
    Li, Xihong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Lipopolysaccharide induces epithelial-mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway
    Qin, Y.
    Zhao, P.
    Chen, Y.
    Liu, X.
    Dong, H.
    Zheng, W.
    Li, C.
    Mao, X.
    Li, J.
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (02) : 224 - 234
  • [9] IL-6 Activates the Mineralocorticoid Receptor via the JAK2/STAT3 Pathway
    Moyer, Hayley Catherine
    Krishnamurthy, Ashwini
    Mallick, Rickta
    Hoover, Robert S.
    Wynne, Brandi Michele
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [10] MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2/STAT3 signaling pathway in non-small cell lung cancer
    Cai, Kai
    Li, Hong-Xia
    Li, Pan-Pan
    Guo, Zi-Jian
    Yang, Yang
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 2527 - 2534